Familial RUNX1 Grant Program

Funding Agency:
Alexs Lemonade Stand Foundation

The RUNX1 Research Program and Alex’s Lemonade Stand Foundation are delighted to announce their continued partnership and the launch of a new funding opportunity for early career investigators: the RRP and ALSF RUNX1 Early Career Investigator Program. 

Key Objective: To promote the establishment of a new generation of translational and clinical researchers interested in tackling inherited hematologic malignancy predisposition disorders with a focus on RUNX1-familial platelet disorder. We believe that providing capital to early career investigators not only injects funding to where it is needed most, but also cultivates a new cohort of investigators who will be invested in an area of research that historically has had limited attention.

The RUNX1 Early Career Investigator grant is a 3-year award designed to fund research in strategies leading to the development of therapies to prevent the transition from pre-leukemia to leukemia for patients with RUNX1-FPD. 

Collaboration and data sharing are a priority for this research program. The RUNX1 Research Program and ALSF host an annual scientific meeting that brings together grant recipients and other scientists. Grant recipients are expected to present their progress as part of the annual review. 

2019 Quarterly Application Deadlines: June 27th, September 26th, December 26th

Agency Website

Eligibility Requirements

Applicants must have an M.D., Ph.D. or dual M.D., Ph.D. (D.O., MBBS or equivalent) and be within 5 years of their first faculty appointment as an Assistant Professor or equivalent. Associate and Full Professors are ineligible. If still at the Instructor level, the applicant must have a commitment from the Department Chair/Division Chief at the time of grant submission for an Assistant Professor position within one year of receiving the award. 



Amount Description

A RUNX1 Early Career Investigator Grant is $180,000 over 3 years (maximum $60,000 per year may be requested)

Funding Type



Junior Faculty


Medical - Clinical Science
Medical - Translational

External Deadline

September 26, 2019